Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 9, 2012, Pages 1149-1156

  Khoury, P ^a   Zagallo, P ^b   Talar Williams, C ^c   Santos, C S ^a   Dinerman, E ^a   Holland, N C ^d   Klion, A D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

Churg Strauss syndrome; eosinophilia; hypereosinophilic syndrome

Indexed keywords

BIOLOGICAL MARKER; EOTAXIN; INTERLEUKIN 8; PREDNISONE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; AGED; ARTICLE; ASTHMA; BIOPSY; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINUSITIS; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMOKINE CCL11; CHEMOKINE CCL17; CHURG-STRAUSS SYNDROME; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERLEUKIN-8; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84865027959     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02873.x     Document Type: Article

References (24)

1. Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010; 126: 45-49.
2. Radice A, Sinico RA,. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 2005; 38: 93-103.
3. Pagnoux C, Guillevin L,. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 2010; 22: 21-28.
4. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-1100.
5. Dallos T, Heiland GR, Strehl J, Karonitsch T, Gross WL, Moosig F, et al. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis Rheum 2010; 62: 3496-3503.
6. Guilpain P, Auclair JF, Tamby MC, Servettaz A, Mahr A, Weill B, et al. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome. Ann N Y Acad Sci 2007; 1107: 392-399.
7. Polzer K, Karonitsch T, Neumann T, Eger G, Haberler C, Soleiman A, et al. Eotaxin-3 is involved in Churg-Strauss syndrome-a serum marker closely correlating with disease activity. Rheumatology (Oxford) 2008; 47: 804-808.
8. Saito H, Tsurikisawa N, Tsuburai T, Oshikata C, Akiyama K,. Cytokine production profile of CD4 + T cells from patients with active Churg-Strauss syndrome tends toward Th17. Int Arch Allergy Immunol 2009; 149 (Suppl 1): 61-65.
9. Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008; 358: 1215-1228.
10. Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL, et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 2004; 104: 3038-3045.
11. Paganelli R, Ansotegui IJ, Sastre J, Lange CE, Roovers MH, de Groot H, et al. Specific IgE antibodies in the diagnosis of atopic disease. Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy 1998; 53: 763-768.
12. Williams PB, Siegel C, Portnoy J,. Efficacy of a single diagnostic test for sensitization to common inhalant allergens. Ann Allergy Asthma Immunol 2001; 86: 196-202.
13. Taira T, Matsuyama W, Mitsuyama H, Kawahara KI, Higashimoto I, Maruyama I, et al. Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Clin Exp Immunol 2007; 148: 241-247.
14. Mitsuyama H, Matsuyama W, Iwakawa J, Higashimoto I, Watanabe M, Osame M, et al. Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome. Chest 2006; 129: 407-411.
15. Zwerina J, Bach C, Martorana D, Jatzwauk M, Hegasy G, Moosig F, et al. Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study. Rheumatology (Oxford) 2011; 50: 1823-1827.
16. Schmitt WH, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross WL,. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998; 41: 445-452.
17. Schonermarck U, Csernok E, Trabandt A, Hansen H, Gross WL,. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 2000; 18: 457-463.
18. Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, et al. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood 1991; 78: 2626-2632.
19. Kanbe N, Kurosawa M, Igarashi N, Tamura A, Yamashita T, Kurimoto F, et al. Idiopathic hypereosinophilic syndrome associated with elevated plasma levels of interleukin-10 and soluble interleukin-2 receptor. Br J Dermatol 1998; 139: 916-918.
20. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O,. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996; 271: 21514-21521.
21. de Lavareille A, Roufosse F, Schandene L, Stordeur P, Cogan E, Goldman M,. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. Eur J Immunol 2001; 31: 1037-1046.
22. Chu YT, Chiang W, Wang TN, Hung CH, Jong YJ, Wu JR,. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma. J Microbiol Immunol Infect 2007; 40: 162-167.
23. Hoffmann HJ, Nielsen LP, Harving H, Heinig JH, Dahl R,. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11. Clin Respir J 2008; 2: 149-157.
24. Tsurikisawa N, Saito H, Tsuburai T, Oshikata C, Ono E, Mitomi H, et al. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma. J Allergy Clin Immunol 2008; 122: 610-616.